Transcode Therapeutics Inc. (RNAZ) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-12-19
5:32 pm
Purchase
2021-12-3113GTransCode Therapeutics, Inc.
RNAZ
Dudley Robert Michael2
10.600%
2increase
(New Position)
Filing
History
2022-10-27
08:08 am
Sale
2022-10-2613GTransCode Therapeutics, Inc.
RNAZ
Orin Hirschman0
0.000%
-2decrease
(Position Closed)
Filing
History
2022-02-11
3:06 pm
Purchase
2021-12-3113GTransCode Therapeutics, Inc.
RNAZ
Orin Hirschman2
9.900%
0increase
(+1.46%)
Filing
History
2021-07-20
5:55 pm
Purchase
2021-07-0913GTransCode Therapeutics, Inc.
RNAZ
Orin Hirschman2
9.900%
2increase
(New Position)
Filing
History
Goto Prev, 0, 1